metronidazole has been researched along with imipenem, anhydrous in 109 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (12.84) | 18.7374 |
1990's | 41 (37.61) | 18.2507 |
2000's | 28 (25.69) | 29.6817 |
2010's | 16 (14.68) | 24.3611 |
2020's | 10 (9.17) | 2.80 |
Authors | Studies |
---|---|
Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F | 1 |
Appelbaum, PC; Credito, KL; Ednie, LM | 1 |
Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Betriu, C; Culebras, E; Gómez, M; López, F; Picazo, JJ; Rodríguez-Avial, I | 1 |
Hsueh, PR; Huang, YT; Liao, CH; Lin, HY; Liu, CY; Yen, LC | 1 |
Jacobus, NV; McDermott, LA; Snydman, DR | 2 |
Appelbaum, PC; Ednie, LM | 1 |
Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE | 1 |
Schaadt, R; Shinabarger, D; Sweeney, D; Zurenko, G | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chong, Y; Jeong, SH; Kim, MS; Lee, K; Lee, Y; Park, Y; Yong, D | 1 |
Bavari, S; Bowlin, TL; Butler, MM; Moir, DT; Panchal, RG; Peet, NP; Shinabarger, DL; Williams, JD | 1 |
Baquero, F; Reig, M | 1 |
Jansen, A; Kresken, M; Rodloff, AC; Werner, H | 1 |
Spencer, RC; Wilcox, MH; Winstanley, TG | 1 |
Heikkinen, E; Seppänen, J; Uhari, M | 1 |
Bellantone, R; Brisinda, G; Crucitti, F; Doglietto, GB; Pacelli, F | 1 |
Bremmelgaard, A; Jansen, JE | 1 |
Christensen, FB; French, JI; McGregor, JA | 1 |
Allen, N; Semel, JD | 1 |
Jacobus, NV; Petersen, PJ; Testa, RT; Weiss, WJ | 1 |
Burkitt, DS; Donovan, IA; Lowe, P; Wise, R | 1 |
Appelbaum, PC; Jacobs, MR; Spangler, SK | 2 |
Christou, NV; De Santis, M; Poenaru, D | 1 |
Echols, RM; Kowalsky, SF; McCormick, EM | 1 |
Dehne, M; el Abed, K; Hofmann, W; Kroh, U; Lennartz, H | 1 |
Gill, CJ; Ponticas, S; Shungu, DL | 1 |
Lahnborg, G; Nord, CE | 1 |
Naden, M; Watt, B | 1 |
Traub, WH | 1 |
Andrew, JH; Downes, J | 1 |
Broze, B; de Lame, PA; De Mees, J; Droissart, R; Nolens, VP; Staudt, JP; Verstraeten, ME | 1 |
Johnson, E; Kennedy, RH; Leaper, DJ; Roberts, N; Sutton, A | 1 |
Avery, D; Kennedy, R; Leaper, D; Leow, C; Thomas, W | 1 |
Bourgault, AM; Delorme, L; Fijalkowski, C; Lamothe, F; Malouin, F | 1 |
Defresne, N; Husson, M; Klastersky, J; Van der Auwera, P; Van Laethem, Y | 1 |
Hand, WL; Holman, JW; King-Thompson, N | 1 |
Maskell, JP; Nasu, M; Williams, JD; Williams, RJ | 1 |
Fresnadillo-Martínez, MJ; García-García, MI; García-Rodríguez, JA; García-Sánchez, E; García-Sánchez, JE; Trujillano-Martín, I | 1 |
Budanov, SV; Rezvan, SP; Sidorenko, SV | 1 |
Edwards, R; Gazis, A; Greenwood, D; Ispahani, P; Turner, P; Weston, V | 1 |
Dubois, J; Gourdeau, M; Lamothe, F; Turgeon, P; Turgeon, V | 1 |
Gerbracht, K; Manncke, B; Schumacher, U; Werner, H | 1 |
Brook, I; Ledney, GD | 1 |
Currie, J; Gomersall, LN; Jeffrey, R | 1 |
Anderson, LH; Mehm, WJ; Muhvich, KH | 1 |
Couroux, PR; Hussain, Z; Lannigan, R; Massey, VE; Schieven, BC | 1 |
Blenkinsop, J; Finnis, D; Gartell, P; Karran, SE; Karran, SJ; Sutton, G | 1 |
Cherubin, CE; Citron, DM; Goldstein, EJ; Hillier, SL | 1 |
Avila-Campos, MJ; Carvalho, MA; Zelante, F | 1 |
Bjornson, HS; Bohnen, JM; Coulter, HO; Dellinger, EP; Echols, RM; Haverstock, DC; Hill, CS; Reinhart, HH; Rotstein, OD; Simms, HH; Solomkin, JS; Vogel, SB | 1 |
Aucher, P; Fauchère, JL; Grollier, G; Saunier, JP; Sebald, M | 1 |
Nord, CE | 1 |
Hecht, DW; Osmolski, JR | 1 |
Angerås, MH; Darle, N; Ekelund, M; Engström, L; Hamnström, K; Holme, JB; Takala, J; Viste, A | 1 |
Bossuyt, M; De Backer, T; Schoenaers, J | 1 |
Cheng, AF; Chung, SS; Ling, TK; Sung, JJ; Yiu, PY | 1 |
Barie, PS; Baumgartner, TF; Dellinger, EP; Rotstein, OD; Solomkin, JS; Vogel, SB; Yang, JY | 1 |
Bohnen, JM; Dellinger, EP; Rostein, OD; Solomkin, JS | 1 |
Edlund, C; Nord, CE; Sabouri, S | 1 |
Cáceres, M; Carera, E; Nord, CE; Palmgren, AC | 1 |
Hamilton-Miller, JM; Shah, S | 1 |
Betriu, C; Gómez, M; Palau, ML; Picazo, JJ; Sánchez, A | 1 |
Hertle, L; Ludwig, K; Pühse, G; Roos, N | 1 |
Paladino, JA; Solomkin, JS; Walters, DJ | 1 |
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
Dieleman, LA; Freitag, R; Li, F; Linde, HJ; Rath, HC; Sartor, RB; Schölmerich, J; Schultz, M | 1 |
Edwards, R; Fodor, E; Nagy, E; Sóki, J; Szoke, I; Urban, E | 1 |
Haristoy, X; Labia, R; Lozniewski, A; Mory, F | 1 |
Kot, K; Meszaros, J; Rokosz, A; Sawicka-Grzelak, A; Łuczak, M | 1 |
Brunskill, NJ; West, SD | 1 |
Meisel-Mikołajczyk, F; Obuch-Woszczatyński, P; Pituch, H; Rokosz, A; Sawicka-Grzelak, A; Łuczak, M | 1 |
Blasco Huelva, A; González Palomino, A; Keituqwa Yáñez, T; Marcos García, M; Pardo Romero, G; Píno Rivero, V; Trinidad Ruiz, G | 1 |
Greenberg, GR | 1 |
Barie, PS; Dellinger, EP; Grasela, TH; Rotstein, OD; Walawander, CA | 1 |
Luczak, M; Pawłowska, J; Rokosz, A; Sawicka-Grzelak, A | 1 |
Almassi, GH; Brown, KR; Edmiston, CE; Kehl, KS; Krepel, CJ; Lewis, BD; Loehrl, TA; Seabrook, GR; Smith, TL; Somberg, LB; Towne, JB | 1 |
Al-Ebous, AD; Al-Jahmi, M; Al-Zuriqat, AN; Hiasat, B; Sarayrah, M | 1 |
Beger, HG; Gansauge, F; Isenmann, R; Kriese, D; Poch, B; Rozdzinski, E; Schwarz, M | 1 |
Caviezel, A; Garbino, J; Lew, D; Matulionyte, R; Morel, P; Uckay, I; Villiger, P | 1 |
Kadzielska, J; Kierzkowska, M; Rokosz, A; Sawicka-Grzelak, A; Łuczak, M | 1 |
Chong, Y; Kim, CK; Kim, JM; Kim, MS; Kim, S; Lee, K; Roh, KH; Yong, D; Yum, JH | 1 |
Eden, A; Le Falher, G; Le Moing, V; Lesnik, A; Makinson, A; Reynes, J | 1 |
Avila-Campos, MJ; Merino, VR; Nakano, V; Nascimento e Silva, Ad; Wexler, HM | 1 |
Funke, M; Janssen, E; Rodloff, AC; Schaumann, R | 1 |
Božić, M; Jovanović, M; Knežević, M; Rašić, D; Stojković, M | 1 |
Chen, J; He, J; Miao, X; Wu, X; Xie, Y; Xu, B; Xu, M; Yu, L; Zhang, W | 1 |
Hariu, K; Katayama, Y; Kinoshita, Y; Niwa, H | 1 |
Chmura, A; Deborska-Materkowska, D; Durlik, M; Kierzkowska, M; Majewska, A; Mlynarczyk, A; Mlynarczyk, G; Paczek, L; Sawicka-Grzelak, A | 1 |
Bettoli, V; Join-Lambert, O; Nassif, A | 1 |
Compain, F; Guerot, E; Jarraud, S; Podglajen, I; Richaud, C; Rossi, B; Rostane, H | 1 |
Ferstl, PG; Grammatikos, G; Jozsa, K; Kempf, VA; Reinheimer, C; Waidmann, O; Zeuzem, S | 1 |
Chen, PX; Fu, JL; Gu, XX; Jiang, HX; Yang, L; Zhang, LJ | 1 |
Chen, C; Chen, K; Dong, N; Hu, D; Huang, J; Jin, X; Li, Y; Xie, Y | 1 |
AlAzmi, A; AlHashem, G; Jamal, W; Khodakhast, FB; Rotimi, VO; Sόki, J | 1 |
Ikebuchi, K; Imai, K; Kawamura, T; Kodana, M; Maeda, T; Maesaki, S; Mitsutake, K; Murakami, T; Ogane, K; Onodera, A; Sakai, J; Takeuchi, S; Tarumoto, N | 1 |
Abdul Wahab, Z; Amin Nordin, S; Ibrahim, R; Ishak, N | 1 |
Fukuda, K; Hobo, S; Kinoshita, Y; Kuroda, T; Kuwano, A; Minami, T; Mita, H; Nagata, SI; Niwa, H; Tamura, N | 1 |
Bastiaanssen, TFS; Cryan, JF; Dinan, TG; Fitzgerald, P; Fulling, C; Moloney, GM; O'Connor, R; O'Riordan, KJ; Schellekens, H | 1 |
Ahmadinejad, Z; Emaneini, M; Fazeli, MS; Feizabadi, MM; Jasemi, S; Sadeghpour Heravi, F; Sechi, LA | 1 |
Angrup, A; Bala, K; Ray, P; Sood, A | 1 |
Chawla, K; Gupta, A; Kumar, A; Shenoy, PA | 1 |
Cheng, VC; Chow, KH; Fang, H; Ho, PL; Li, X; Tong, MK; Yan, MK | 1 |
Álvarez-Pérez, S; Anega, B; Blanco, JL; García, ME; Hernández, M | 1 |
4 review(s) available for metronidazole and imipenem, anhydrous
Article | Year |
---|---|
Resistance of anaerobic bacteria to antimicrobial agents in Spain.
Topics: Bacteria, Anaerobic; Cefoxitin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Imipenem; Metronidazole; Penicillin Resistance; Spain | 1992 |
Antibiotics should be used as first-line therapy for Crohn's disease.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Crohn Disease; Humans; Imipenem; Metronidazole; Time Factors; Treatment Outcome; Vancomycin | 2004 |
Acute post-surgical bilateral orbital gas-producing infection - a case report and literature review.
Topics: Acute Disease; Anti-Bacterial Agents; Drug Therapy, Combination; Emphysema; Eye Infections, Bacterial; Eyelid Diseases; Glucocorticoids; Humans; Imipenem; Male; Methylprednisolone; Metronidazole; Middle Aged; Orbital Diseases; Postoperative Complications; Staphylococcal Infections; Tomography, X-Ray Computed; Vancomycin | 2012 |
Antibiotic Treatment of Hidradenitis Suppurativa.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Clindamycin; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Imipenem; Maintenance Chemotherapy; Metronidazole; Moxifloxacin; Remission Induction; Rifampin | 2016 |
18 trial(s) available for metronidazole and imipenem, anhydrous
Article | Year |
---|---|
Imipenem-cilastatin vs. tobramycin and metronidazole for appendicitis-related infections.
Topics: Adolescent; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Male; Metronidazole; Tobramycin | 1992 |
Single dose imipenem-cilastatin compared with three doses of cefuroxime and metronidazole as prophylaxis in elective colorectal surgery: a prospective randomized study.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefuroxime; Cilastatin; Colorectal Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Metronidazole; Middle Aged; Postoperative Complications; Premedication; Prospective Studies | 1991 |
Intramuscular imipenem/cilastatin treatment of upper reproductive tract infection in women: efficacy and use characteristics.
Topics: Cesarean Section; Cilastatin; Cilastatin, Imipenem Drug Combination; Consumer Behavior; Costs and Cost Analysis; Drug Administration Schedule; Drug Combinations; Endometritis; Female; Humans; Imipenem; Injections, Intramuscular; Metronidazole; Patient Compliance; Pelvic Inflammatory Disease | 1991 |
A comparison between imipenem and metronidazole prophylaxis against sepsis following appendicectomy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Appendectomy; Child; Cilastatin; Drug Combinations; Emergencies; Humans; Imipenem; Infusions, Intravenous; Metronidazole; Middle Aged; Premedication; Prospective Studies; Randomized Controlled Trials as Topic; Surgical Wound Infection | 1990 |
Imipenem versus tobramycin--antianaerobe antibiotic therapy in intra-abdominal infections.
Topics: Abdomen; Adult; Aged; Bacteria, Anaerobic; Bacterial Infections; Clindamycin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Metronidazole; Middle Aged; Prospective Studies; Random Allocation; Tobramycin | 1990 |
Imipenem/cilastatin as monotherapy in severe infections: comparison with cefotaxime in combination with metronidazole and cloxacillin. Report from a Norwegian Study Group.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cloxacillin; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Metronidazole; Random Allocation; Thienamycins | 1987 |
Randomized comparison of imipenem/cilastatin and ceftazidime in the empiric therapy of severe abdominal infections. A multicenter study.
Topics: Bacterial Infections; Ceftazidime; Cilastatin; Cyclopropanes; Digestive System Diseases; Dipeptidases; Drug Evaluation; Drug Therapy, Combination; Humans; Imipenem; Metronidazole; Random Allocation; Thienamycins | 1987 |
Treatment of acute bacterial peritonitis: a trial of imipenem/cilastatin against ampicillin-metronidazole-gentamicin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Gentamicins; Humans; Imipenem; Male; Metronidazole; Middle Aged; Peritonitis; Random Allocation; Thienamycins | 1987 |
Treatment of intra-abdominal infections using imipenem/cilastatin.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Drug Combinations; Female; Gentamicins; Humans; Imipenem; Male; Metronidazole; Peritonitis | 1987 |
Comparative serum bactericidal activity against test anaerobes in volunteers receiving imipenem, clindamycin, latamoxef and metronidazole.
Topics: Adult; Bacteria, Anaerobic; Clindamycin; Female; Humans; Imipenem; Male; Metronidazole; Moxalactam; Random Allocation; Thienamycins | 1987 |
Imipenem prophylaxis in elective colorectal surgery.
Topics: Aged; Bacterial Infections; Cefuroxime; Colon; Female; Humans; Imipenem; Male; Metronidazole; Postoperative Complications; Premedication; Rectum; Surgical Wound Infection | 1993 |
Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group.
Topics: Abdomen; Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Infections; Infusions, Intravenous; Metronidazole; Middle Aged; Treatment Outcome | 1996 |
A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections.
Topics: Abdomen; Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefuroxime; Cilastatin; Drug Therapy, Combination; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 1996 |
A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.
Topics: Abdomen; Abdominal Abscess; Adult; Aged; Antitrichomonal Agents; Appendicitis; Cefepime; Cephalosporins; Cilastatin; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Imipenem; Infections; Male; Metronidazole; Middle Aged; Peritonitis; Treatment Outcome | 1997 |
The role of oral antimicrobials for the management of intra-abdominal infections.
Topics: Abdomen; Administration, Oral; Adult; Aged; Anti-Infective Agents; Antitrichomonal Agents; APACHE; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Metronidazole; Middle Aged; Prospective Studies; Surgical Wound Infection | 1998 |
Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections.
Topics: Abdomen; Aged; Anti-Infective Agents; Bacterial Infections; Cilastatin; Ciprofloxacin; Cost-Benefit Analysis; Double-Blind Method; Drug Combinations; Female; Humans; Imipenem; Male; Metronidazole; Middle Aged; Protease Inhibitors; Thienamycins | 1999 |
Management of diabetic foot in a Jordanian hospital.
Topics: Amikacin; Amputation, Surgical; Anti-Bacterial Agents; Ceftazidime; Chemotherapy, Adjuvant; Debridement; Diabetic Foot; Drug Combinations; Drug Monitoring; Humans; Imipenem; Kidney Diseases; Length of Stay; Lincomycin; Metronidazole; Patient Selection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Severity of Illness Index; Treatment Outcome; Wound Healing; Wound Infection | 2005 |
A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
Topics: Abdominal Cavity; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacterial Infections; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Hospitals, University; Humans; Imipenem; Male; Metronidazole; Middle Aged | 2007 |
87 other study(ies) available for metronidazole and imipenem, anhydrous
Article | Year |
---|---|
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
Antimicrobial susceptibilities and clinical sources of Dialister species.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae | 2007 |
Comparative antianaerobic activities of doripenem determined by MIC and time-kill analysis.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Colony Count, Microbial; Doripenem; Humans; Microbial Sensitivity Tests | 2008 |
In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot wounds.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Diabetic Foot; Doripenem; Humans; Microbial Sensitivity Tests | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Spain; Species Specificity; Time Factors | 2008 |
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Blood; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Taiwan | 2008 |
In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2008 |
Antianaerobic activity of sulopenem compared to six other agents.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Gram-Negative Bacteria; Humans; Lactams; Microbial Sensitivity Tests; Prodrugs | 2009 |
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 2009 |
In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent.
Topics: Anti-Bacterial Agents; Bacteria; Enterococcus; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Oxazolidinones; Staphylococcus; Streptococcus | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Bacteroides fragilis; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Positive Cocci; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Republic of Korea | 2010 |
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
Topics: Anti-Bacterial Agents; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests | 2010 |
German multicentre study on the in vitro susceptibility of Bacteroides species. The German Bacteroides Study Group.
Topics: Anti-Bacterial Agents; Bacteroides; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillins | 1992 |
Effect of pH on antibiotics used to treat anaerobic infection.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Cefoxitin; Clindamycin; Drug Therapy, Combination; Hydrogen-Ion Concentration; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam | 1992 |
Susceptibility testing of anaerobic bacteria. Regression lines for six antibiotics determined with and without prediffusion.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Cefoxitin; Clindamycin; Colony Count, Microbial; Erythromycin; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillins; Regression Analysis; Time Factors | 1991 |
Seizures in patients simultaneously receiving theophylline and imipenem or ciprofloxacin or metronidazole.
Topics: Aged; Ciprofloxacin; Drug Interactions; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Imipenem; Male; Metronidazole; Middle Aged; Monitoring, Physiologic; Seizures; Theophylline | 1991 |
In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.
Topics: Amikacin; Animals; Bacterial Infections; Bacteroides fragilis; Carbapenems; Ceftazidime; Cilastatin; Ciprofloxacin; Dipeptidases; Drug Therapy, Combination; Escherichia coli; Female; Imipenem; Klebsiella pneumoniae; Metronidazole; Mice; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Staphylococcus; Streptococcus; Thienamycins | 1991 |
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. cen
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteroides; Bacteroides Infections; beta-Lactamase Inhibitors; beta-Lactamases; Cefoxitin; Clavulanic Acid; Clavulanic Acids; Fusobacterium; Fusobacterium Infections; Imipenem; Metronidazole; Microbial Sensitivity Tests; Ticarcillin; United States | 1990 |
Comparative serum bactericidal activity of ceftizoxime/metronidazole, ceftizoxime, clindamycin, and imipenem against obligate anaerobic bacteria.
Topics: Adult; Anti-Bacterial Agents; Bacteria, Anaerobic; Ceftizoxime; Clindamycin; Drug Combinations; Female; Humans; Imipenem; Male; Metronidazole; Serum Bactericidal Test | 1990 |
Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole.
Topics: Amoxicillin; Bacteroides; Cefoxitin; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Fusobacterium; Imipenem; Metronidazole; Microbial Sensitivity Tests; Ticarcillin | 1990 |
[Dosage adjustment of drugs during continuous hemofiltration. Results and practical consequences of a prospective clinical study].
Topics: Adult; Aged; Cefotaxime; Ceftazidime; Digitoxin; Digoxin; Hemofiltration; Humans; Imipenem; Kidney Failure, Chronic; Metronidazole; Middle Aged; Netilmicin; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Theophylline; Tobramycin; Vancomycin | 1989 |
Comparative in vitro antimicrobial susceptibilities of a special panel of 74 Bacteroides fragilis group isolates in Wilkins-Chalgren agar with and without sheep blood.
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Blood; Culture Media; Imipenem; Metronidazole; Microbial Sensitivity Tests; Sheep | 1989 |
Efficacy of FCE 22101 compared with imipenem and with gentamicin plus metronidazole in the treatment of experimental intra-abdominal infections in rats.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Gentamicins; Imipenem; Male; Metronidazole; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Time Factors | 1989 |
The growth-inhibitory properties of meropenem against anaerobes of clinical importance.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Clindamycin; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Metronidazole; Microbial Sensitivity Tests; Thienamycins | 1989 |
Clostridium perfringens type A. Comparison of in vitro and in vivo activity of twelve antimicrobial drugs.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Clostridium perfringens; Fosfomycin; Gas Gangrene; Imipenem; Metronidazole; Mice; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Thienamycins; Vancomycin | 1986 |
Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillins; Ticarcillin | 1988 |
Bacteroides fragilis resistant to both metronidazole and imipenem.
Topics: Adult; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Microbial; Humans; Imipenem; Male; Metronidazole; Thienamycins | 1986 |
Entry of roxithromycin (RU 965), imipenem, cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear leukocytes.
Topics: Anti-Bacterial Agents; Cefotaxime; Cell Membrane; Humans; Hydrogen-Ion Concentration; Imipenem; In Vitro Techniques; Leucomycins; Metronidazole; Neutrophils; Temperature; Thienamycins; Trimethoprim | 1987 |
In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; beta-Lactams; Cefotaxime; Cefoxitin; Cefsulodin; Cephalosporins; Cephamycins; Imipenem; Lincomycin; Metronidazole; Moxalactam | 1981 |
In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Cefoxitin; Chloramphenicol; Clindamycin; Fluoroquinolones; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Ornidazole; Quinolones | 1995 |
[Comparative in vitro activity of ampicillin, cefoperazone and their combinations with sulbactam, as well as that of other antibiotics against anaerobic organisms].
Topics: Ampicillin; Bacteria, Anaerobic; Cefoperazone; Cefoxitin; Drug Combinations; Drug Resistance, Microbial; Imipenem; Metronidazole; Microbial Sensitivity Tests; Sulbactam | 1995 |
Simultaneous resistance to metronidazole, co-amoxiclav, and imipenem in clinical isolate of Bacteroides fragilis.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Clavulanic Acids; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Empyema, Pleural; Female; Humans; Imipenem; Metronidazole | 1995 |
Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers.
Topics: Bacteroides fragilis; Cefotetan; Cefoxitin; Clindamycin; Drug Resistance, Microbial; Imipenem; Longitudinal Studies; Metronidazole; Microbial Sensitivity Tests | 1994 |
In vitro activity of meropenem compared with imipenem, metronidazole, ampicillin, and ampicillin/sulbactam against anaerobes.
Topics: Ampicillin; Bacteria, Anaerobic; Bacterial Infections; Clindamycin; Humans; Imipenem; Meropenem; Metronidazole; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 1994 |
The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
Topics: Abscess; Animals; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Feces; Female; Imipenem; Immunocompromised Host; Liver; Metronidazole; Mice; Microbial Sensitivity Tests; Ofloxacin; Whole-Body Irradiation | 1994 |
Amoebiasis: a rare cause of cardiac tamponade.
Topics: Adult; Cardiac Tamponade; Drainage; Humans; Imipenem; Liver Abscess, Amebic; Male; Metronidazole; Rupture, Spontaneous; Time Factors | 1994 |
Evaluation of antimicrobials combined with hyperbaric oxygen in a mouse model of clostridial myonecrosis.
Topics: Animals; Clindamycin; Combined Modality Therapy; Disease Models, Animal; Female; Gas Gangrene; Hyperbaric Oxygenation; Imipenem; Injections, Intraperitoneal; Metronidazole; Mice; Mice, Inbred Strains; Necrosis; Penicillins; Survival Rate; Time Factors | 1994 |
Comparison of the E-test and reference agar dilution method for susceptibility of gram-negative anaerobic organisms.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Cefoxitin; Clindamycin; Gram-Negative Anaerobic Bacteria; Imipenem; Metronidazole; Microbial Sensitivity Tests | 1993 |
Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Cefoxitin; Clindamycin; Drug Resistance, Microbial; Imipenem; Meropenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin; Sulbactam; Thienamycins | 1993 |
Distribution of biotypes and antimicrobial susceptibility of Actinobacillus actinomycetemcomitans.
Topics: Adolescent; Adult; Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Antitrichomonal Agents; Bacterial Typing Techniques; Cefoxitin; Cephamycins; Clindamycin; Dental Plaque; Drug Resistance, Microbial; Erythromycin; Female; Humans; Imipenem; Lincomycin; Male; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Penicillins; Periodontitis; Tetracycline; Thienamycins | 1995 |
Meningitis due to enterotoxigenic Bacteroides fragilis.
Topics: Antibodies, Bacterial; Antitrichomonal Agents; Bacteroides fragilis; Bacteroides Infections; Blotting, Western; Diagnosis, Differential; Enterotoxins; False Positive Reactions; Humans; Imipenem; Infant; Latex Fixation Tests; Male; Meningitis, Bacterial; Meningitis, Haemophilus; Metronidazole; Thienamycins | 1996 |
In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; In Vitro Techniques; Metronidazole; Microbial Sensitivity Tests; Quinolones | 1996 |
Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Ciprofloxacin; Clindamycin; Culture Media; Drug Resistance, Microbial; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Imipenem; In Vitro Techniques; Metronidazole; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin | 1996 |
Management of necrotizing fasciitis in the neck.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cilastatin; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Fasciitis, Necrotizing; Focal Infection, Dental; Gentamicins; Humans; Hyperbaric Oxygenation; Imipenem; Male; Metronidazole; Neck; Penicillins; Protease Inhibitors; Thienamycins | 1996 |
An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Antacids; Anti-Bacterial Agents; Bismuth; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Imipenem; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Tetracycline | 1996 |
Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Cefoxitin; Cephamycins; Clindamycin; Fluoroquinolones; Imipenem; Metronidazole; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Thienamycins | 1998 |
Antimicrobial susceptibility of anaerobic bacteria from the intestinal microflora of healthy children and antimicrobial-treated children in Nicaragua.
Topics: Age Factors; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteroides; Cefoxitin; Cephamycins; Child, Preschool; Chloramphenicol; Clindamycin; Clostridium; Drug Resistance, Microbial; Feces; Female; Humans; Imipenem; Infant; Intestines; Male; Metronidazole; Microbial Sensitivity Tests; Penicillins; Thienamycins | 1998 |
Comparative anti-anaerobic activity of Men 10700, a penem antibiotic.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Fusobacterium; Imipenem; Lactams; Metronidazole; Microbial Sensitivity Tests; Peptostreptococcus; Veillonella | 1998 |
In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamase Inhibitors; Cefoxitin; Ceftizoxime; Chloramphenicol; Clavulanic Acid; Clindamycin; Drug Therapy, Combination; Enzyme Inhibitors; Imipenem; Metronidazole; Mezlocillin; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Species Specificity; Sulbactam; Tazobactam; Thienamycins; Ticarcillin | 1999 |
[Intra- and peri-renal gas formation. Bilateral emphysematous pyelonephritis].
Topics: Aged; Combined Modality Therapy; Fatal Outcome; Female; Humans; Imipenem; Kidney; Lumbar Vertebrae; Metronidazole; Nephrectomy; Postoperative Complications; Pyelonephritis; Reoperation; Spinal Stenosis; Tomography, X-Ray Computed | 1999 |
Incidence of beta-lactamase production and antimicrobial susceptibility of anaerobic gram-negative rods isolated from pus specimens of orofacial odontogenic infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin Resistance; Anti-Bacterial Agents; Bacteroidaceae Infections; beta-Lactam Resistance; beta-Lactamases; Cefmetazole; Cephalosporin Resistance; Cephamycins; Chi-Square Distribution; Clindamycin; Erythromycin; Fusobacterium; Gram-Negative Anaerobic Straight, Curved, and Helical Rods; Gram-Negative Bacterial Infections; Humans; Imipenem; Metronidazole; Middle Aged; Minocycline; Periodontal Diseases; Porphyromonas; Prevotella; Sulbactam; Thienamycins; Tooth Diseases | 2001 |
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.
Topics: Animals; Bacteroides; Ciprofloxacin; Colitis; Enterobacteriaceae; Female; HLA-B27 Antigen; Imipenem; Interleukin-1; Metronidazole; Mice; Mice, Inbred BALB C; Rats; Rats, Inbred F344; Vancomycin | 2001 |
Occurrence of metronidazole and imipenem resistance among Bacteroides fragilis group clinical isolates in Hungary.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; DNA Transposable Elements; Drug Resistance, Microbial; Genes, Bacterial; Humans; Hungary; Imipenem; Metronidazole; Thienamycins | 2001 |
Antimicrobial susceptibilities of clinical Desulfovibrio isolates.
Topics: Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Desulfovibrio; Drug Combinations; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillin G | 2001 |
[Use of the Etest method for antimicrobial susceptibility testing of obligate anaerobes].
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Clindamycin; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin | 2001 |
Complications associated with influenza infection.
Topics: Acute Kidney Injury; Alphainfluenzavirus; Drug Therapy, Combination; Humans; Imipenem; Influenza, Human; Kidney Tubules; Liver Diseases; Lung; Lung Abscess; Male; Metronidazole; Middle Aged; Necrosis; Pneumonia, Pneumococcal; Pseudomonas Infections; Tomography, X-Ray Computed | 2002 |
[Susceptibility to antimicrobial drugs of enterotoxin producing strains of Bacteroides fragilis isolated from different countries].
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Clindamycin; Drug Resistance, Bacterial; Enterotoxins; Humans; Imipenem; Metalloendopeptidases; Metronidazole; Polymerase Chain Reaction; Species Specificity | 2002 |
[Otogenic intracranial abscesses. Description of 6 cases].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Brain Abscess; Cefotaxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Male; Metronidazole; Middle Aged; Otitis Media; Tomography, X-Ray Computed | 2004 |
The cost-effectiveness of cefepime plus metronidazole versus imipenem/cilastatin in the treatment of complicated intra-abdominal infection.
Topics: Adult; Aged; APACHE; Bacterial Infections; Cefepime; Cephalosporins; Cilastatin; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Imipenem; Male; Metronidazole; Middle Aged; Probability; Retrospective Studies; Treatment Outcome | 2004 |
[ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactam Resistance; beta-Lactamases; Catalase; Clindamycin; Drug Resistance, Bacterial; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Poland | 2004 |
Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Fluoroquinolones; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quinolines | 2005 |
Effect of early and late antibiotic treatment in experimental acute pancreatitis in rats.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Cholagogues and Choleretics; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Imipenem; Intestines; Male; Metronidazole; Pancreatitis, Acute Necrotizing; Random Allocation; Rats; Rats, Wistar; Taurocholic Acid; Time Factors | 2007 |
[Characteristic of clinical strains of gram-negative obligate anaerobes].
Topics: Anti-Bacterial Agents; Bacteroides; beta-Lactam Resistance; beta-Lactamases; Clavulanic Acids; Drug Resistance, Bacterial; Gram-Negative Anaerobic Bacteria; Hospitals; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin; Poland; Retrospective Studies; Ticarcillin | 2007 |
Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Cefoxitin; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Republic of Korea | 2009 |
In vitro activity of ceftaroline against a broad spectrum of recent clinical anaerobic isolates.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Anaerobic; Ceftaroline; Ceftriaxone; Cephalosporins; Clindamycin; Fluoroquinolones; Imipenem; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Quinolines; Tigecycline | 2011 |
[Two cases of pulmonary gangrene in HIV-infected patients: favorable outcome without surgery].
Topics: Acetamides; Adult; Alcoholism; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Gangrene; Gentamicins; HIV Infections; Humans; Imipenem; Linezolid; Lung; Male; Metronidazole; Necrosis; Ofloxacin; Oxazolidinones; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Smoking; Tomography, X-Ray Computed | 2011 |
Antimicrobial resistance and prevalence of resistance genes in intestinal Bacteroidales strains.
Topics: Analysis of Variance; Anti-Bacterial Agents; Bacteroides; Child; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Imipenem; Intestines; Metronidazole; Microbial Sensitivity Tests | 2011 |
In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kinetics.
Topics: Anti-Infective Agents; Bacteroides fragilis; Clindamycin; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam | 2012 |
Antimicrobial resistance and prevalence of resistance genes of obligate anaerobes isolated from periodontal abscesses.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Proteins; Bacteriological Techniques; Bacteroidaceae Infections; beta-Lactam Resistance; beta-Lactamases; Cefixime; Cephradine; Clindamycin; Doxycycline; Drug Resistance, Bacterial; Female; Genes, Bacterial; Humans; Imipenem; Male; Methyltransferases; Metronidazole; Middle Aged; Periodontal Abscess; Prevotella; Roxithromycin; Tetracycline Resistance | 2014 |
Dominant obligate anaerobes revealed in lower respiratory tract infection in horses by 16S rRNA gene sequencing.
Topics: Animals; Anti-Infective Agents; Bacteria, Anaerobic; Bacteroides; Base Sequence; Bronchoalveolar Lavage Fluid; Clindamycin; Cluster Analysis; Horse Diseases; Horses; Imipenem; Metronidazole; Molecular Sequence Data; Phylogeny; Prevotella; Respiratory Tract Infections; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Species Specificity | 2014 |
Specific character of anaerobic bacterial infections in patients treated in transplantation wards at one of the clinical hospitals in Warsaw.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Gram-Positive Bacteria; Humans; Imipenem; Immunocompromised Host; Metronidazole; Microbial Sensitivity Tests; Poland | 2014 |
Photo Quiz: A 44-Year-Old Kidney Transplant Patient with Pneumonia.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; beta-Lactamases; Clostridioides difficile; Enterobacter cloacae; Female; Humans; Imipenem; Kidney Failure, Chronic; Kidney Transplantation; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Respiratory Insufficiency; Vancomycin | 2017 |
Severe infection with multidrug-resistant
Topics: Adult; Anti-Infective Agents; beta-Lactamases; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Europe; Fever; Humans; Imipenem; Male; Metronidazole; Microbial Sensitivity Tests; Salmonella enterica; Salmonella Infections; Serogroup; Thailand; Travel; Ultrasonography | 2017 |
The first isolation of Clostridium difficile RT078/ST11 from pigs in China.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Chickens; China; Ciprofloxacin; Clostridioides difficile; Ducks; Imipenem; Metronidazole; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction; Ribotyping; Swine; Tetracycline; Vancomycin | 2019 |
Tetratrichomonas in pyopneumothorax.
Topics: Aged, 80 and over; Antiprotozoal Agents; Cilastatin; Empyema, Pleural; Female; Humans; Imipenem; Metronidazole; Pleural Effusion; Pneumothorax; Streptococcal Infections; Streptococcus anginosus; Trichomonadida; Trichomonas Infections | 2019 |
Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Toxins; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Clindamycin; Drug Resistance, Bacterial; Feces; Female; Humans; Imipenem; Kuwait; Male; Meropenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin; Prevalence; Prospective Studies; Respiratory Tract Infections; Sepsis; Tigecycline; Wound Infection | 2020 |
Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Blood Culture; DNA Transposable Elements; Doripenem; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Imipenem; Japan; Meropenem; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Piperacillin, Tazobactam Drug Combination; Prevalence; Sulbactam; Tertiary Care Centers | 2020 |
Susceptibility patterns of anaerobes isolated from clinical specimens in tertiary Hospital, Malaysia.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Clindamycin; Drug Resistance, Bacterial; Humans; Imipenem; Malaysia; Metronidazole; Microbial Sensitivity Tests; Tertiary Care Centers; Vancomycin | 2020 |
Single-dose pharmacokinetics of orally administered metronidazole and intravenously administered imipenem in healthy horses and computer-based simulation of pleural fluid concentrations with multiple dosing.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Computer Simulation; Horses; Imipenem; Metronidazole | 2020 |
Maternal antibiotic administration during a critical developmental window has enduring neurobehavioural effects in offspring mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anxiety; Ciprofloxacin; Cognition; Female; Homing Behavior; Imipenem; Male; Metronidazole; Mice; Mice, Inbred C57BL; Penicillin V; Pregnancy; Prenatal Exposure Delayed Effects; Social Behavior; Vancomycin; Vocalization, Animal | 2021 |
Antibiotic resistance pattern of Bacteroides fragilis isolated from clinical and colorectal specimens.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Clindamycin; Cross-Sectional Studies; DNA, Bacterial; Drug Resistance, Bacterial; Gastrointestinal Tract; Genes, Bacterial; Humans; Imipenem; Inpatients; Metalloendopeptidases; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Polymerase Chain Reaction; RNA, Ribosomal, 16S; Tetracycline | 2021 |
Comparative evaluation of agar dilution and broth microdilution by commercial and in-house plates for Bacteroides fragilis group: An economical and expeditious approach for resource-limited settings.
Topics: Agar; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests | 2021 |
Clinico-microbiological profile of
Topics: Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Chloramphenicol; Clindamycin; Drug Resistance, Bacterial; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin | 2021 |
Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong, 2020-2021.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Clindamycin; Hong Kong; Imipenem; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Retrospective Studies; RNA, Ribosomal, 16S | 2023 |
In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clindamycin; Clostridioides difficile; Clostridium Infections; Clostridium perfringens; Diarrhea; Dog Diseases; Dogs; Erythromycin; Fidaxomicin; Humans; Imipenem; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2023 |